Neo Ivy Capital Management Catalent, Inc. Transaction History
Neo Ivy Capital Management
- $294 Million
- Q3 2024
A detailed history of Neo Ivy Capital Management transactions in Catalent, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 17,808 shares of CTLT stock, worth $1.13 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
17,808Holding current value
$1.13 Million% of portfolio
0.37%Shares
10 transactions
Others Institutions Holding CTLT
# of Institutions
216Shares Held
73.2MCall Options Held
477KPut Options Held
2.02M-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl4MShares$254 Million1.29% of portfolio
-
Tig Advisors, LLC New York, NY1.54MShares$98 Million6.1% of portfolio
-
Morgan Stanley New York, NY1.45MShares$91.9 Million0.01% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...